COMMUNIQUÉS West-GlobeNewswire

Avricore Health Extends Closing of Placement
20/07/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, July 19, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the " [...]
Repligen Corporation Announces Closing of Public Offerings of $138.1 Million of Common Stock and $287.5 Million of 0.375% Convertible Senior Notes due 2024, Including Full Exercise of Underwriters’ Options
20/07/2019
WALTHAM, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced the closing of its previously announced concurrent underwritten public offerings of an aggregate of 1, [...]
BioTelemetry, Inc. to Release Second Quarter 2019 Earnings Results on July 30, 2019
19/07/2019
MALVERN, Pa., July 19, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2019 earnings on Tuesday, July 30 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will [...]
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/07/2019
HOLLISTON, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Michael Rossi being named Chief Financial Officer on July 18, 2019, the Compensation [...]
RavenQuest Completes Non-Brokered Private Placement
19/07/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, July [...]
Amedisys Announces Second Quarter Earnings Release and Conference Call Date
19/07/2019
BATON ROUGE, La., July 19, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the second quarter ended June 30, 2019, after the market closes on July 31, 2019. The [...]
Major Shareholder Announcement
19/07/2019
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 19, 2019 – Genmab A/S (CSE: GEN, Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that [...]
Harvard Bioscience Schedules Second Quarter 2019 Earnings Conference Call for July 25 at 4:30 PM ET
19/07/2019
HOLLISTON, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for the second quarter ended June 30, 2019 after market close on July 25, 2019 and hold a [...]
Retrotope Announces Completion of Series C Preferred Financing and Addition of a Lead Investor on the Board of Directors
19/07/2019
Round co-led by existing inside investors and new outside family office LOS ALTOS, Calif., July 19, 2019 (GLOBE NEWSWIRE) -- Retrotope announced today that it closed a Series C financing, enabling expansion of its [...]
Ossur Hf : Össur acquires College Park Industries
19/07/2019
Reykjavik, 19 July 2019 Össur has signed an agreement to acquire College Park Industries, a global provider of lower and upper limb prostheses and supporting services. College Park has over 140 employees and is [...]
Revive Therapeutics Announces Approval of CSE Listing and Delisting from TSX-V
19/07/2019
TORONTO, July 19, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and [...]
Coherus BioSciences Announces New Employment Inducement Grants
19/07/2019
REDWOOD CITY, Calif., July 19, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective July 18, 2019, the compensation committee of the company’s board of directors granted five [...]
Generex Biotechnology Announces Satisfaction of Debt Obligation
19/07/2019
Retires $3,150,972 in debt and satisfies all associated obligations Payment in GNBT restricted common shares at the July 16, 2019 closing price MIRAMAR, Fla., July 19, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology [...]
Orion Corporation: Managers’ transactions – Virve Laitinen
19/07/2019
ORION CORPORATION MANAGERS’ TRANSACTIONS 19 July 2019 at 15.45 EETS Orion Corporation: Managers’ transactions – Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
SeaSpine to Report Second Quarter 2019 Financial Results on August 1, 2019
19/07/2019
CARLSBAD, Calif., July 19, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Momenta Pharmaceuticals Announces Date of Second Quarter 2019 Financial Results Conference Call and Webcast
19/07/2019
CAMBRIDGE, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
19/07/2019
ATLANTA, July 19, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal [...]
Minneapolis Based MedTech SubioMed™ Start-Up Gains Certification as a Minnesota Angel Tax Credit Company
19/07/2019
MINNEAPOLIS, July 19, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today [...]
Dova Pharmaceuticals Announces DOPTELET® (avatrombopag) Now Commercially Available in the United States for Treatment of Chronic Immune Thrombocytopenia (ITP)
19/07/2019
DOPTELET Has Differentiated Profile as The Only Oral Thrombopoietin Receptor Agonist (TPO-RA) Approved for Treatment of ITP Without Food Type Restrictions DURHAM, N.C., July 19, 2019 (GLOBE NEWSWIRE) -- Dova [...]

Pages